A carregar...
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
BACKGROUND: The novel coronavirus (SARS-CoV-2) shares approximately 80% whole genome sequence identity and 66% spike (S) protein identity with that of SARS-CoV. The cross-neutralization between these viruses is currently not well-defined. METHODS: Here, by using the live SARS-CoV-2 virus infection a...
Na minha lista:
| Publicado no: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7372296/ https://ncbi.nlm.nih.gov/pubmed/32707445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102890 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|